Valuation: Implanet SA

Market Cap 2.35Cr 2.68Cr 2.22Cr 2.02Cr 3.79Cr 256.68Cr 3.81Cr 27Cr 10Cr 131.13Cr 10Cr 9.84Cr 421.44Cr P/E 2024
-2.85x
P/E 2025 -5.8x
Enterprise Value 2.64Cr 3.01Cr 2.49Cr 2.27Cr 4.26Cr 288.52Cr 4.29Cr 30Cr 12Cr 147.4Cr 11Cr 11Cr 473.72Cr EV / Sales 2024
2x
EV / Sales 2025 2.23x
Free-Float
33.85%
Yield 2024 *
-
Yield 2025 -
1 day+1.87%
1 week-3.88%
Current month-11.10%
1 month-13.45%
3 months+2.12%
6 months-21.44%
Current year-17.68%
1 week 0.16
Extreme 0.156
0.17
1 month 0.16
Extreme 0.156
0.19
Current year 0.15
Extreme 0.15
0.29
1 year 0.15
Extreme 0.15
0.45
3 years 0.04
Extreme 0.035
0.45
5 years 0.04
Extreme 0.035
0.68
10 years 0.04
Extreme 0.035
61.6
Manager TitleAgeSince
Chief Executive Officer - 27/11/2012
Director of Finance/CFO - 01/09/2015
Chief Operating Officer - -
Director TitleAgeSince
Chairman 71 06/04/2011
Director/Board Member - 22/01/2013
Director/Board Member - 10/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
+1.87%-3.88%-48.45%+81.56% 2.68Cr
+0.97%-1.00%-26.10%-5.23% 10TCr
+0.35%-1.90%-23.58%-3.12% 1.12TCr
-0.29%-5.73%+89.55%+102.21% 910.46Cr
-1.29%+3.12%-49.04%-67.22% 414.28Cr
-0.91%+6.44%-25.51%+26.97% 249.03Cr
+2.46%-8.18%-8.82%-61.91% 203.82Cr
-3.28%+0.48% - - 193.94Cr
-1.43%+0.29%-24.06%-32.26% 153.03Cr
Average -0.17%-1.15%-14.50%+5.12% 1.52TCr
Weighted average by Cap. +0.67%-1.20%-18.51%-0.26%

Financials

2024 2025
Net sales 94.06L 1.07Cr 88.84L 80.96L 1.52Cr 102.74Cr 1.53Cr 11Cr 4.12Cr 52Cr 4.02Cr 3.94Cr 168.68Cr 1.25Cr 1.42Cr 1.18Cr 1.07Cr 2.01Cr 136.25Cr 2.02Cr 14Cr 5.46Cr 70Cr 5.34Cr 5.22Cr 223.7Cr
Net income -43.66L -49.75L -41.23L -37.58L -70.34L -48Cr -70.85L -4.93Cr -1.91Cr -24Cr -1.87Cr -1.83Cr -78Cr -43.82L -49.94L -41.39L -37.72L -70.6L -48Cr -71.11L -4.95Cr -1.92Cr -24Cr -1.87Cr -1.83Cr -79Cr
Net Debt 45.69L 52.07L 43.15L 39.33L 73.61L 50Cr 74.14L 5.16Cr 2Cr 25Cr 1.95Cr 1.91Cr 82Cr 29.15L 33.22L 27.53L 25.09L 46.97L 32Cr 47.3L 3.29Cr 1.28Cr 16Cr 1.25Cr 1.22Cr 52Cr
Logo Implanet SA
Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).
Employees
46
Date Price Change Volume
25/26/25 €0.1634 +1.87% 1,12,280
24/26/24 €0.1604 0.00% 77,422
23/26/23 €0.1604 -5.31% 54,495
22/26/22 €0.1694 +3.04% 35,804
21/26/21 €0.1644 -3.29% 21,741
  1. Stock Market
  2. Stocks
  3. ALIMP Stock